CDC25C and cancer: Additionally, the ROC curve demonstrated that CDC25 family could universally discriminate between cancer patients and non-cancer controls across 12 cancer types (Fig. S2B, area under the curve (AUC) > 0.7) with high diagnostic efficiency in COAD (AUC > 0.9).